Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Hydrolases (EC 3) | ||||||
GTPase KRas (KRAS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of KRAS | |||||
Induced Change | Uridine triphosphate concentration: decrease (FC = 0.43) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Lung cancer [ICD-11: 2C25] | |||||
Details | It is reported that overexpression of KRAS leads to the decrease of uridine triphosphate levels compared with control group. | |||||
Mitochondrial carrier (MC) | ||||||
Solute carrier family 25 member 33 (SLC25A33) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Recombinant protein addition of SLC25A33 | |||||
Induced Change | Uridine triphosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that recombinant protein addition of SLC25A33 leads to the increase of uridine triphosphate levels compared with control group. | |||||
Solute carrier family 25 member 36 (SLC25A36) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Recombinant protein addition of SLC25A36 | |||||
Induced Change | Uridine triphosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that recombinant protein addition of SLC25A36 leads to the increase of uridine triphosphate levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Uridine triphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of uridine triphosphate levels compared with control group. | |||||
Transferases (EC 2) | ||||||
Arylamine N-acetyltransferase 1 (NAT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Knockout of NAT1 | |||||
Induced Change | Uridine triphosphate concentration: decrease (FC = 0.04) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockout of NAT1 leads to the decrease of uridine triphosphate levels compared with control group. | |||||
Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
Induced Change | Uridine triphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Prostate cancer [ICD-11: 2C82] | |||||
Details | It is reported that inhibition of ICMT leads to the decrease of uridine triphosphate levels compared with control group. | |||||
Pyridoxal kinase (PDXK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Knockout (CRISPR/Cas9 sgRNA) of Pdxk | |||||
Induced Change | Uridine triphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
Details | It is reported that knockout of Pdxk leads to the decrease of uridine triphosphate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.